Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LORAZEPAM | 2MG | TABLET | Resolved | 2021-12-01 | 2021-12-20 | 150252 |
| APO-LORAZEPAM | 2MG | TABLET | Resolved | 2022-04-01 | 2022-05-13 | 157698 |
| APO-LOSARTAN | 50MG | TABLET | Resolved | 2017-03-12 | 2017-03-16 | 722 |
| APO-LOSARTAN | 50MG | TABLET | Actual shortage | 2018-05-01 | 2019-03-15 | 47652 |
| APO-LOSARTAN | 100MG | TABLET | Actual shortage | 2018-05-15 | 2019-04-11 | 49490 |
| APO-LOSARTAN | 25MG | TABLET | Actual shortage | 2018-07-11 | 2019-03-15 | 55284 |
| APO-LOSARTAN | 100MG | TABLET | Actual shortage | 2018-12-27 | 2019-04-17 | 70523 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2018-03-27 | 2018-09-11 | 44105 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2018-05-15 | 2018-09-15 | 49493 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-07-15 | 2018-09-15 | 55807 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2017-10-24 | 2018-09-11 | 26827 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-02-13 | 2018-09-10 | 39656 |
| APO-LOXAPINE | 5MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19075 |
| APO-LOXAPINE | 10MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19078 |
| APO-LOXAPINE | 25MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19081 |
| APO-LOXAPINE | 50MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19084 |
| APO-MELOXICAM | 15MG | TABLET | Resolved | 2017-03-10 | 2017-07-13 | 378 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2017-03-11 | 2019-11-25 | 586 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2017-03-11 | 2018-05-02 | 589 |
| APO-MELOXICAM | 7.5MG | TABLET | Resolved | 2017-05-04 | 2017-10-05 | 8871 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |